GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-0526 |
Atrial appendage
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-0726 |
Esophagus - mucosa
|
PAXgene |
2
|
4 pieces, target squamous mucosa up to ~0.25mm, sloughing
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-0826 |
Esophagus - muscularis
|
PAXgene |
1
|
6 pieces, confirmed target muscularis
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-0926 |
Liver
|
PAXgene |
1
|
2 pieces, moderate passive congestion
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1026 |
Omentum
|
PAXgene |
1
|
2 pieces, fascia/mesothelial hyperplasia, vascular elements are ~10% of tissue, rep delineated
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1126 |
Pancreas
|
PAXgene |
2
|
2 pieces, islets still visible, rep encircled, advanced degenerative changes. Moderate parenchymal autolysis
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1226 |
Spleen
|
PAXgene |
2
|
2 pieces, moderate congestion & autolysis
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1326 |
Kidney - cortex
|
PAXgene |
3
|
6 pieces, ~30% adherent fat; glomeruli present, advanced tubular autolysis
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1426 |
Adrenal glands
|
PAXgene |
2
|
2 pieces, cortex, ~30% adherent/interstitial fat/fibrous tissue, rep delineated
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1626 |
Uterus
|
PAXgene |
1
|
2 pieces. myometrium
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1726 |
Vagina
|
PAXgene |
2
|
6 pieces, squamous mucosa sloughing, up to ~70 microns
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1826 |
Stomach
|
PAXgene |
3
|
6 pieces; target mucosa up to ~0.6mm, advanced autolysis/sloughing
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-1926 |
Ileum
|
PAXgene |
3
|
6 pieces, advanced mucosal glandular autolysis; target lymphoid aggregates are ~10% of tissue, delineated
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2026 |
Gastroesophageal junction
|
PAXgene |
1
|
6 pieces, confirmed target muscularis; trace "contaminant squamous mucosa, <1mm nubbin, delineated
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2126 |
Colon, transverse
|
PAXgene |
3
|
6 pieces, target mucosa up to ~0.4mm, complete glandular mucosal autolysis, remnant lamina propria intact
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2226 |
Artery - tibial
|
PAXgene |
0
|
2 pieces, no significant atherosis or adherent fat
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2326 |
Nerve - tibial
|
PAXgene |
0
|
2 pieces, trace partial rim of adherent fat up to ~0.5mm, rep delineated
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2426 |
Skin, leg
|
PAXgene |
0
|
6 pieces, minimal dermal fat; squamous epithelium up to ~35 microns
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2526 |
Adipose tissue
|
PAXgene |
0
|
3 pieces (fragemented), ~10% fascia/vascular elements, rep delineated
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2626 |
Muscle, skeletal
|
PAXgene |
0
|
2 pieces, ~10% interstital fat/vascular elements
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2726 |
Minor salivary glands
|
PAXgene |
1
|
2 pieces, ~80% glandular elements, rest is connective elements/squamous mucosa
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2826 |
Colon, sigmoid
|
PAXgene |
1
|
6 pieces, confirmed target muscularis, separate fragment of serosal fat, delineated
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-2926 |
Brain - cerebellum
|
PAXgene |
1
|
4 pieces, no abnormalities
|
Acceptable
|
 |
GTEX-1LH75
|
51-60
|
Female
|
GTEX-1LH75-3026 |
Pituitary gland
|
PAXgene |
1
|
1 piece, ~80% adenohypophysis; ~20% neurohypophysis, delineated, 3.5 x1.5mm nubbin
|
Acceptable
|
 |